Transfusion-transmissible infections among blood donors in Kathmandu, Nepal. 2009

Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal. ashishcshrestha@yahoo.com

BACKGROUND Screening of transfusion-transmissible infections (TTIs) among blood donors can be a cost-effective approach to monitor the prevalence, distribution, and trends of the infections among healthy-looking individuals. The study aimed to determine the seroprevalence of four TTIs, human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis, among blood donors in Kathmandu, Nepal. METHODS A total of 21,716 units of blood were tested for the presence of anti-HIV 1/2 IgG/IgM, HBsAg, anti-HCV IgG/IgM, and anti-Treponema pallidum IgG/IgM/IgA using commercial ELISA kits following standard protocols. Statistical analysis was performed using WinPepi Ver 3.8. RESULTS Seroprevalence of HIV, HBV (HBsAg), HCV and syphilis were observed to be 0.12% (95% CI = 0.08-0.18), 0.47% (95% CI = 0.39-0.57), 0.64% (95% CI = 0.54-0.75) and 0.48% (95% CI = 0.40-0.59) respectively. TTIs were dominant among male blood donors compared to female blood donors. Higher HCV seroprevalence among males compared to females was statistically significant. HIV prevalence was highest among blood donors in the age group 31 to 40 years (P > 0.5). HBV, HCV and syphilis prevalence was highest among blood donors 41 to 50 years age group, 21 to 30 years age group, and 51 to 60 years age group respectively (P < 0.05). HIV and HBV prevalence was relatively higher among first-time donors, whereas HCV and syphilis was relatively higher among the repeated donors (P > 0.05). CONCLUSIONS It is of utmost importance to continue screening donated blood with highly sensitive and specific tests and to counsel donors who are positive to any of the above infections. It is absolutely necessary to avoid the transmission of infection from repeat donors.

UI MeSH Term Description Entries
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009390 Nepal Country located in southern Asia, between China and India. The capital is Kathmandu. Federal Democratic Republic of Nepal
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated

Related Publications

Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
September 2022, African health sciences,
Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
January 2010, Clinical laboratory,
Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
May 2011, Journal of infection in developing countries,
Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
November 2013, Transfusion,
Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
July 2023, BMJ open gastroenterology,
Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
January 2016, BMC hematology,
Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
November 2017, Laboratory medicine,
Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
January 2008, Kathmandu University medical journal (KUMJ),
Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
January 2012, Asian journal of transfusion science,
Ashish Chandra Shrestha, and Prakash Ghimire, and Bishnu Raj Tiwari, and Manita Rajkarnikar
September 2019, Blood transfusion = Trasfusione del sangue,
Copied contents to your clipboard!